Clinical trial
Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
NCT00349505 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Unknown status
Key facts
| NCT number | NCT00349505 |
|---|---|
| Title | Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma |
| Official title | Phase II Study of Intra-Peritoneal Hyper-Thermic Chemotherapy as Consolidation Therapy for Advanced Epithelial Ovarian Carcinoma |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Epithelial Ovarian Carcinoma, Figo Stage IIIC |
| Intervention type | Procedure |
| Interventions | hyper thermic chemo + surgery |
| Enrollment | 67 |
| Start date | Sep 1, 2004 |
| First posted | Jul 7, 2006 |
| Last update posted | Oct 6, 2006 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: